🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
6.51
+0.01 (0.15%)
Nov 20, 2026, 2:16 PM EST - Market open

Alignment Healthcare Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Alignment Healthcare stock has a consensus rating of "Buy" and an average price target of $10.79. The average 1-year stock price forecast is 65.75% higher than the current stock price, while the lowest is $8.00 (+22.89%) and the highest is $17 (+161.14%).

Price Target: $10.79 (+65.75%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$8.00$10.79$10$17
Change+22.89%+65.75%+53.61%+161.14%

Analyst Ratings

The average analyst rating for Alignment Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy10109966
Buy223333
Hold222266
Sell000000
Strong Sell000000
Total141414141515

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Leerink Partners
No rating
Leerink Partners
Buy
Maintains
$26 → $17
BuyMaintains$26 → $17+161.14%Nov 2, 2026
TD Cowen
TD Cowen
Buy
Reiterates
$12 → $10
BuyReiterates$12 → $10+53.61%Nov 2, 2026
Bank of America Securities
Bank of America Securities
Hold
Maintains
n/a
HoldMaintainsn/an/aOct 30, 2026
J.P. Morgan
J.P. Morgan
Buy
Maintains
$10 → $8
BuyMaintains$10 → $8+22.89%Oct 30, 2026
UBS
UBS
Hold
Maintains
$9 → $8
HoldMaintains$9 → $8+22.89%Oct 30, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
5.27B
from 3.95B
Increased by 33.34%
Revenue Next Year
6.58B
from 5.27B
Increased by 24.95%
EPS This Year
0.27
from 0.32
Decreased by -17.55%
EPS Next Year
0.56
from 0.27
Increased by 109.43%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.17B1.43B1.82B2.70B3.95B5.27B
Revenue Growth
21.74%22.81%27.16%48.25%46.06%33.34%
Net Income
-195.29M-149.55M-148.02M-128.04M-724.00K-13.72M
EPS
----0.320.27
EPS Growth
------17.55%
Forward PE
----56.4324.57
Free Cash Flow
----113.15M115.00M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High5.3B
Avg5.3B
Low5.2B

Revenue Growth

Revenue Growth202620272028
High
34.5%
Avg
33.3%
Low
32.8%

EPS Forecast

EPS202620272028
High0.29
Avg0.27
Low0.24

EPS Growth

EPS Growth202620272028
High
-9.8%
Avg
-17.6%
Low
-25.3%